LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.21 in-line revenue of $0.16M misses by $1.9M
2023-11-08 07:08:47 ET
More on Lexicon Pharmaceuticals
- Looking Back In On Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals Underway With Inpefa, But A Lot Of Hard Work
- Lexicon Rolls Out Inpefa For Heart Failure Amid Robust Competition
- Lexicon to present data on cost-effectiveness of Inpefa on Tuesday
- Express Scripts to list Lexicon's Inpefa as preferred Medicare product
For further details see:
Lexicon Pharmaceuticals GAAP EPS of -$0.21 in-line, revenue of $0.16M misses by $1.9M